Faraz Khan, MD

Specialties: Resident and Surgery

No Patient Experience Reviews – Why Not?

Gundersen Health System requires a minimum of 30 completed patient surveys in a 12-month period for each clinician before posting a clinician’s rating. Industry best practice is clear that more data provides a more accurate picture of the patient experience.

Main Location

La Crosse Campus

1900 South Avenue La Crosse, WI 54601
Office Phone: (608) 775-2331

Profile

Personal Interests

Dr. Kahn was born in Houston, Texas, and raised in central New Jersey. He enjoys almost any sports activity and loves being outdoors. He found the culture of patient centered care at Gundersen to be unmatched at any other hospital for which he has worked. After residency, Dr. Kahn and his fiancé, Sofia, hope to work in smaller critical access hospitals and in under served regions throughout the world.

Education and Training

College

Union College

Medical School

Albany Medical College

Residency

Gundersen Medical Foundation

Professional Memberships

American College of Surgeons (ACS)
Gold Humanism Honor Society (GHHS)

Published Works

Folch EE, Pritchett MA, Nead MA, et al. Electromagnetic navigation bronchoscopy for peripheral pulmonary lesions: one-year results of the prospective, multicenter NAVIGATE Study. J Thorac Oncol. 2018. doi: S1556-0864(18)33456-7 [pii]
Khanal A, Lashari BH, Kruthiventi S, et al. The risk of second primary malignancy in patients with stage Ia non-small cell lung cancer: a U.S. population-based study. Acta Oncol. 2018;57(2):239-243. doi: 10.1080/0284186X.2017.1390250 [doi]
Khanal A, Lashari BH, Kruthiventi S, et al. The risk of second primary malignancy in patients with stage Ia non-small cell lung cancer: a U.S. population-based study. Acta Oncol. 2017:1-5. doi: 10.1080/0284186X.2017.1390250 [doi]
Peters AA, Jamaludin SYN, Yapa KTDS, et al. Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells. Oncogene. 2017;36(46):6490-6500. doi: 10.1038/onc.2017.234 [doi]
Peters AA, Simpson PT, Bassett JJ, et al. Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer. Mol Cancer Ther. 2012;11(10):2158-2168. doi: 10.1158/1535-7163.MCT-11-0965 [doi]
Chang AY, Yeap B, Davis TE, et al. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol. J Clin Oncol. 1996;14(8):2250-2257
Witte RS, Elson PJ, Khandakar J, Trump DL. An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma. Cancer. 1994;73(3):688-691